Brief: First Tracks Biotherapeutics, The Planned Spin-Off Of Anaptys, Secures Commitments Of $145 Million In Private Placement
27/03/2026 13:03
AnaptysBio Inc ANAB.O: FIRST TRACKS BIOTHERAPEUTICS, THE PLANNED SPIN-OFF OF ANAPTYS, SECURES COMMITMENTS OF $145 MILLION IN PRIVATE PLACEMENT Source text: ID:nGNX1Ml9sl Further company coverage: ANAB.O
Recent news on AnaptysBio
See all newsFirst Tracks Biotherapeutics up after $200 mln equity raise
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Brief: Anaptys Announces Second Quarter And Transitional Fiscal Year 2026 Financial Results And Provides Business Update
AnaptysBio Q2 collaboration revenue rises on higher Jemperli royalties